Stay updated on Nivolumab Safety in Chinese Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section with Guangdong and Zhejiang as study sites, and the revision label has been updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:05:27.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The Publications note was updated to indicate that PubMed auto-fills publications and that entries may not be about the study, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:29.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed a general operating-status notice about government funding and NIH/OPM updates from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No substantive changes were detected in the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:05:44.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:28:59.000Z thumbnail image

Stay in the know with updates to Nivolumab Safety in Chinese Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.